Opioid Settlement & Litigation

Indiana has been hit hard by the opioid epidemic. The rates of opioid prescribing in Indiana reached a peak in 2012 when, on average, there were 112 opioid prescriptions for every 100 residents in the state. From 2012 through 2016, there were 58 Indiana counties with opioid prescribing rates greater than 100 prescriptions per 100 residents. The Attorney General's office is leading the fight to hold the manufacturers, distributors, and dispensers/pharmacies accountable. To date, the Attorney General's Office has secured more than $1 billion for Hoosiers in opioid settlements alone, and will continue fighting to hold the manufacturers, distributors, and pharmacies accountable.

• $26 billion national settlement with Johnson & Johnson, AmerisourceBergen, Cardinal Health and McKesson. Indiana’s share of the settlement is approximately $508 million and all cities, towns, and counties in the state are participating in the settlement.
• $3.1 billion national settlement with Walmart to resolve allegations that the company contributed to the opioid addiction crisis. Indiana's estimated share is $59.4 million.
• $219 million agreement for Indiana with CVS and Walgreens to settle allegations against the two pharmacies that they contributed to the opioid crisis through their conduct in the distribution and dispensing of prescription drugs.
• $5.27 billion agreements with Allergan and Teva to settle allegations that the manufacturers contributed to the opioid crisis. Indiana’s estimated share is $128 million.
• $350 million national settlement with Publicis, a marketing company, to resolve allegations that the company’s marketing strategies for companies like Purdue Pharma contributed to the opioid crisis. Indiana’s share of the settlement is approximately $7.6 million.
• $1.4 billion settlement between Kroger Co. and 30 states to settle allegations the company contributed to the opioid crisis. Indiana’s share is approximately $43 million.
• Indiana is also part of bankruptcy settlements with Mallinckrodt and Endo International, drug manufacturers. The bankruptcy court requires that funds from these settlements be used for abatement or restricted spending.
• $7.4 billion settlement with the Sackler family and Purdue Pharma to resolve allegations related to the company’s aggressive marketing of opioids under the Sacklers’ ownership. Indiana’s share is up to $100 million.
• 720 million national settlement with eight drug manufactures. Indiana's share is approximately $16.5 million.

The settlements are governed by Indiana Code §§ 4-6-15. Under the terms of the statute governing distribution (IC 4-6-15-4), those cities and towns receiving less than $5,000 annually in abatement funding will have their distribution sent to the county. Subdivisions that hired their own attorneys and litigated on their own will also have their attorney fees deducted from their settlement payment, which will decrease the amount they will receive. For purposes of accounting for your settlement payments, please refer to the guidelines that were distributed in 2022 by the State Board of Accounts (SBOA). https://www.in.gov/sboa/files/September_-Volume-432.pdf

For information about reporting requirements on the use of settlement and the use of the state’s 50% share of the proceeds, please contact the Family and Social Services Administration (FSSA) or visit https://www.in.gov/recovery/settlement/